tommy john surgery

Dr. James Andrews explains why Tommy John surgery is on the rise

25 Comments

Dr. James Andrews was on Sirius/XM radio’s “Power Alley” with Mike Ferrin and Jim Duquette yesterday, talking about Tommy John surgery. He was asked why there seem to be so many guys needing TJ surgery these days.

His answer: it’s not an anomaly, it’s a trend. And an alarming one, he says, in that so many more of the surgeries he’s performing are for high school pitchers as opposed to professionals with a few years under their belt. Kids are bigger and stronger these days, and their ability to throw harder is outpacing the development of their ulnar collateral ligaments.

But the biggest risk factor he and his researchers are seeing: year-round baseball. The fact that not only do pitchers throw year-round, but that they are pitching in competition year-round, and don’t have time to recover. Also: young players are playing in more than one league, where pitch count and innings rules aren’t coordinated. Another factor: the radar gun. Young pitchers who throw over 85 or so are at risk, and all of them who are on a major league track are throwing that fast or faster, and are going up in effort when scouts with guns are around.

Ultimately, you can’t prevent these injuries. Even for the major leaguers, most of whom were damaged in high school only to have the UCL injuries happen once they’ve hit the pros.

Give a listen to the TJ expert.

Jake Diekman will miss at least half of the 2017 season

TORONTO, ON - OCTOBER 9: Jake Diekman #41 of the Texas Rangers works against the Toronto Blue Jays in the sixth inning during game three of the American League Division Series at Rogers Centre on October 9, 2016 in Toronto, Canada. (Photo by Tom Szczerbowski/Getty Images)
Tom Szczerbowski/Getty Images
Leave a comment

Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.

Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.

The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.

The Blue Jays and Bautista have reached a one year deal

TORONTO, ON - OCTOBER 19:  Jose Bautista #19 of the Toronto Blue Jays looks on during batting practice prior to game five of the American League Championship Series against the Cleveland Indians at Rogers Centre on October 19, 2016 in Toronto, Canada.  (Photo by Vaughn Ridley/Getty Images)
Getty Images
2 Comments

It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.

The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.